To get insight into the direction of changes in the frequency of CD4+Teff and Treg TILs expressing common TCRs, which may accompany tumor regression, we analyzed the abundance of such clones in untreated and DTA-1 treated mice. The gene discussed is CD4; the disease is neoplasm.